{
    "symbol": "NUWE",
    "quarter": 4,
    "year": 2022,
    "date": "2023-02-28 16:32:23",
    "content": " Thank you for joining us in today's conference call to discuss Nuwellis' corporate developments and financial results for the fourth quarter and full year ended December 31, 2022. 2022 proved to be a year of growth for Nuwellis with 42% year-over-year revenue growth in the fourth quarter, a revenue increase of 13% sequential and an 8% revenue growth for the full year. In addition, in the fourth quarter, we announced a peer reviewed publication of a single center 10-year real-world retrospective study of 355 consecutive patients supporting lower heart failure hospitalization and readmissions in a year after using the Aquadex. As for our expansion of our installed base, console placements, the razor in our razor blade model, increased more than 6x in the fourth quarter compared to the year ago period and increased 44% in 2022 versus prior year with focused expansion in key geographic locations and high-volume centers. Revenue for the fourth quarter was $2.3 million, representing 42% year-over-year growth and a 14% sequential increase from the third quarter of 2022. Compared to the third quarter of 2022, SG&A expenses increased by approximately $413,000 or 10%, reflecting increased variable compensation expenses and professional fees in the fourth quarter."
}